Goa sees over 300 liver cirrhosis deaths a year as even teenagers hit the bottle
Goa Medical College sees alarming numbers of chronic liver disease admissions and deaths, with an increase in younger ...
Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren ...
RockyKanaka on MSN17h
Senior Yorkie Was Just About to Be Adopted—Then She Collapsed and was Rushed to the ER
Right before her adoption, Piper, a senior Yorkie, suffered liver failure. She was rushed to the ER and is now receiving the ...
The Lancet10h
Management of hepatocellular carcinoma
Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...
CNET on MSN22h
Sleep Apnea: Different Types, Symptoms and Health Effects
Sleep apnea is more serious than you may think. Here are the symptoms and treatment methods to consider once you get diagnosed.
FiercePharma14h
After asset purchase from Travere, Mirum's Ctexli crosses FDA finish line in rare metabolic disorder
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
News Medical on MSN17h
Exploring EGCG's role in protecting against acetaminophen-induced liver injury
Announcing a new publication for Acta Materia Medica journal. Excessive consumption of acetaminophen (APAP) has emerged as the primary culprit behind drug-induced liver injury (DILI), with ...
FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease
The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...
Healio12h
FDA approves first treatment for rare lipid storage disease
The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...
Combined organ-specific mRNA and lipid nanoparticle therapy could repair damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...